ARVO Annual Meeting

ARVO 2017

May 6-11, 2017 | Baltimore MD

Harvard Ophthalmology takes pride in actively participating in the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting every year. Considered the largest gathering of eye and vision researchers in the world, the meeting attracts more than 11,000 attendees from more than 75 countries. About 45 percent of attendees are from outside the United States. With a central focus on “Global Connections in Vision Research,” this year’s meeting will address the challenges of bridging gaps in scientific knowledge and building effective collaborations.

Harvard Ophthalmology by the Numbers

Harvard Ophthalmology stats for ARVOThis year, more than 230 Harvard Ophthalmology faculty and trainees participated in the annual meeting as course instructors, panelists, lecturers, and more. In addition, 18 faculty and trainees presented 11 papers and posters at the ARVO Imaging in the Eye Conference on May 6. View the full program.

    Harvard Ophthalmology and Mass. Eye and Ear Alumni Association Alumni Reception

    Sunday, May 7, 2017  -  7:30-10:00 pm
    Cocktail reception with hors d'oeuvres
    The Grand, Baltimore
    RSVP by April 21

    Directions
    225 N Charles Street
    Baltimore, MD 21201

    Eric PierceNew tools and methodologies for ocular genetics: Promises and challenges

    Cross-Sectional Group Session
    May 7; 1:30-3:00pm

    Eric Pierce, MD, PhD

    Over the years, genomic research has relied on several technologies to uncover the genetic basis, functional aspects, and genomic mysteries associated with many of the complex and Mendelian ocular diseases.

    Using examples of different ocular diseases, this session detailed some of the successes and challenges associated with some of the contemporary “omic” methods (e.g., whole genome sequencing and RNA sequencing) and bioinformatics/computational tools.

    The session also covered systems biology approaches for integrating multiple data sets to elucidate gene regulatory or disease networks.

    Janey Wiggs, MD, PhDAddressing global blindness and eye diseases through research collaborations

    Workshop
    May 7, 1:30-3:00pm

    Janey Wiggs, MD, PhD

    As much as 90 Percent of the global burden of eye disease is shouldered by developing countries, where many treatable diseases often go undiagnosed. Eighty percent of blindness is considered preventable; however a comprehensive research strategy and international reserach collaborations between the developed and developing world need to increase. Many areas of the world require a coordinated strategy for basic science and health services research in order to reduce the global burden of eye diseases.

    This ARVO session stimulated discussion and addressed current challenges, strategies, and collaborative studies related to eye diseases.

    Mildred Weisenfeld Award for Excellence in Ophthalmology

    May 7, 645-7:30pm


    Alumna Johanna Seddon, MD, discussed macular degeneration epidemiology and risk factors. Dr. Seddon completed her Ophthalmic Pathology and Vitreoretinal fellowships at Harvard Ophthalmology/Mass. Eye and Ear. Currently, she is Professor and Founding Director of the Ophthalmic Epidemiology and Genetics Service at Tufts University and a former trustee and vice-president of ARVO.

    Michael GilmoreThe global problem of antibiotic resistance: Impact on ocular health worldwide and researching alternatives

    Symposium
    May 11, 8:30-10:30am

    Michael Gilmore, PhD

    Antibiotic resistance has been steadily rising worldwide, despite newer classes of antibiotics being developed. This problem impacts those with any predisposing condition or those undergoing ocular surgery. 

    This symposium discussed the current epidemiological trends in resistance worldwide and highlight novel and alternative research strategies that aim to circumvent the problem of antibiotic resistance.

    This symposium was designed for clinicians and basic scientists who are interested in ocular surface and intraocular infections, systemic conditions (e.g., diabetes and immunodeficiencies that predispose patients to ocular infection), and complications arising from ocular surgery.

    Janine ClaytonWomen in Eye and Vision Research Luncheon

    May 9, 1:00-2:30pm
    Hilton Baltimore



    This event provided an opportunity to network with more than 300 ARVO attendees over lunch. Prominent scientists from around the world were invited as guest speakers to share their experiences. Janine Austin Clayton, MD, Director of the Office of Research on Women’s Health at the National Institutes of Health, delivered the keynote presentation. While the luncheon program supports women in eye and vision research, both male and female attendees were welcome. 

    2017 ARVO Foundation/Pfizer Ophthalmics
    Carl Camras Translational Research Award

    Ula Jurkunas, MD

    Top-three “Most Innovative and Interesting” ARVO Poster
    Julia Oswald, PhD, presented her research on retinal ganglion cell replacement during the ARVO Press Conference

    ARVO Gold Fellows, Class of 2017
    Jayakrishna Ambati, MD (alumnus)
    Pedram Hamrah, MD (former faculty)
    Louis Pasquale, MD
    Scheffer Tseng, MD, PhD (alumnus)

    ARVO Silver Fellows, Class of 2017
    Norman Blair, MD (alumnus)
    Samuel Jacobson, MD, PhD (alumnus)
    Michael Young, PhD

    New 2017 Dowling Society Members
    Joan W. Miller, MD

    2018 Friedenwald Award
    Reza Dana, MD, MSc, MPH